<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Chemotherapeutic options for patients with metastasised <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and impaired liver function are limited </plain></SENT>
<SENT sid="1" pm="."><plain>Although <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> and 5-FU are well tolerated as single therapeutic agents, data supporting their use as combination chemotherapy in the setting of severe hepatic dysfunction are insufficient </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: Here, we report on 2 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and severe <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo> secondary to <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>On admission both patients displayed a <z:chebi fb="0" ids="16990">bilirubin</z:chebi> of &gt; 22 mg/dL and an alkaline phosphatase (AP) of &gt; 350 U/L as signs of extensive <z:mpath ids='MPATH_352'>hepatic tumor</z:mpath> spread </plain></SENT>
<SENT sid="4" pm="."><plain>We initiated a 5-FU/<z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>-based combination chemotherapy in both patients </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Liver function and clinical performance improved dramatically within the first cycles of therapy in both patients </plain></SENT>
<SENT sid="6" pm="."><plain>On radiologic evaluation, we observed 1 partial response and one long-term (10 months) disease stabilization </plain></SENT>
<SENT sid="7" pm="."><plain>The toxicity was acceptable in both patients </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: We concluded that <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>-based combination chemotherapies (eg FOLFOX4) may achieve good <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> response without significant side effects in patients with <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> and hepatic dysfunction </plain></SENT>
</text></document>